Cargando…
Preferred Conversation Topics with Respect to Treatment Decisions Among Individuals with Type 2 Diabetes
PURPOSE: Greater knowledge of individuals’ needs and preferences can enhance shared decision-making, which is associated with improved quality of decisions and increased satisfaction. This study aimed to identify and prioritize the attributes (ie conversation topics) that individuals with type 2 dia...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029372/ https://www.ncbi.nlm.nih.gov/pubmed/36960182 http://dx.doi.org/10.2147/PPA.S397647 |
_version_ | 1784910127007006720 |
---|---|
author | Tichler, Anna Hertroijs, Dorijn F L Ruwaard, Dirk Brouwers, Martijn C G J Hiligsmann, Mickaël de Jong, Judith D Elissen, Arianne M J |
author_facet | Tichler, Anna Hertroijs, Dorijn F L Ruwaard, Dirk Brouwers, Martijn C G J Hiligsmann, Mickaël de Jong, Judith D Elissen, Arianne M J |
author_sort | Tichler, Anna |
collection | PubMed |
description | PURPOSE: Greater knowledge of individuals’ needs and preferences can enhance shared decision-making, which is associated with improved quality of decisions and increased satisfaction. This study aimed to identify and prioritize the attributes (ie conversation topics) that individuals with type 2 diabetes find it most important to discuss with their healthcare provider regarding treatment decisions. PATIENTS AND METHODS: First, small group interviews were organized with adults with type 2 diabetes (N=8) treated in primary care to identify the attributes that they find important to discuss regarding treatment decisions. A five-step nominal group technique was applied during the interviews. An object best-worst scaling (BWS) survey was subsequently distributed to individuals with self-reported diabetes participating in the Dutch Health Care Consumer Panel of the Netherlands Institute for Health Services Research (N=600) to determine the relative importance score (RIS) of the identified attributes. A higher RIS indicates a higher level of perceived importance. Subgroup and latent class analyses were performed to explore whether individuals’ demographic and disease characteristics influenced their attribute preferences. RESULTS: A total of 21 attributes were identified during three small group interviews with individuals with type 2 diabetes. Respondents in the BWS survey (N=285) viewed “quality of life” (RIS=11.97), “clinical outcomes” (RIS=10.40), “long-term diabetes complications” (RIS=9.83) and “short-term adverse medication” (RIS=7.72) as the most important in the decision-making process for the treatment of type 2 diabetes. Some differences in attribute preferences were identified according to demographic and disease characteristics. CONCLUSION: In general, individuals with type 2 diabetes not only want to discuss the biological effects of treatments, but also the impact of treatment on their quality of life. Healthcare providers should be aware that attributes are viewed differently by different individuals. This emphasizes the need for tailor-made healthcare decisions, which means eliciting and responding to individual preferences in the decision-making process. |
format | Online Article Text |
id | pubmed-10029372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-100293722023-03-22 Preferred Conversation Topics with Respect to Treatment Decisions Among Individuals with Type 2 Diabetes Tichler, Anna Hertroijs, Dorijn F L Ruwaard, Dirk Brouwers, Martijn C G J Hiligsmann, Mickaël de Jong, Judith D Elissen, Arianne M J Patient Prefer Adherence Original Research PURPOSE: Greater knowledge of individuals’ needs and preferences can enhance shared decision-making, which is associated with improved quality of decisions and increased satisfaction. This study aimed to identify and prioritize the attributes (ie conversation topics) that individuals with type 2 diabetes find it most important to discuss with their healthcare provider regarding treatment decisions. PATIENTS AND METHODS: First, small group interviews were organized with adults with type 2 diabetes (N=8) treated in primary care to identify the attributes that they find important to discuss regarding treatment decisions. A five-step nominal group technique was applied during the interviews. An object best-worst scaling (BWS) survey was subsequently distributed to individuals with self-reported diabetes participating in the Dutch Health Care Consumer Panel of the Netherlands Institute for Health Services Research (N=600) to determine the relative importance score (RIS) of the identified attributes. A higher RIS indicates a higher level of perceived importance. Subgroup and latent class analyses were performed to explore whether individuals’ demographic and disease characteristics influenced their attribute preferences. RESULTS: A total of 21 attributes were identified during three small group interviews with individuals with type 2 diabetes. Respondents in the BWS survey (N=285) viewed “quality of life” (RIS=11.97), “clinical outcomes” (RIS=10.40), “long-term diabetes complications” (RIS=9.83) and “short-term adverse medication” (RIS=7.72) as the most important in the decision-making process for the treatment of type 2 diabetes. Some differences in attribute preferences were identified according to demographic and disease characteristics. CONCLUSION: In general, individuals with type 2 diabetes not only want to discuss the biological effects of treatments, but also the impact of treatment on their quality of life. Healthcare providers should be aware that attributes are viewed differently by different individuals. This emphasizes the need for tailor-made healthcare decisions, which means eliciting and responding to individual preferences in the decision-making process. Dove 2023-03-17 /pmc/articles/PMC10029372/ /pubmed/36960182 http://dx.doi.org/10.2147/PPA.S397647 Text en © 2023 Tichler et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Tichler, Anna Hertroijs, Dorijn F L Ruwaard, Dirk Brouwers, Martijn C G J Hiligsmann, Mickaël de Jong, Judith D Elissen, Arianne M J Preferred Conversation Topics with Respect to Treatment Decisions Among Individuals with Type 2 Diabetes |
title | Preferred Conversation Topics with Respect to Treatment Decisions Among Individuals with Type 2 Diabetes |
title_full | Preferred Conversation Topics with Respect to Treatment Decisions Among Individuals with Type 2 Diabetes |
title_fullStr | Preferred Conversation Topics with Respect to Treatment Decisions Among Individuals with Type 2 Diabetes |
title_full_unstemmed | Preferred Conversation Topics with Respect to Treatment Decisions Among Individuals with Type 2 Diabetes |
title_short | Preferred Conversation Topics with Respect to Treatment Decisions Among Individuals with Type 2 Diabetes |
title_sort | preferred conversation topics with respect to treatment decisions among individuals with type 2 diabetes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029372/ https://www.ncbi.nlm.nih.gov/pubmed/36960182 http://dx.doi.org/10.2147/PPA.S397647 |
work_keys_str_mv | AT tichleranna preferredconversationtopicswithrespecttotreatmentdecisionsamongindividualswithtype2diabetes AT hertroijsdorijnfl preferredconversationtopicswithrespecttotreatmentdecisionsamongindividualswithtype2diabetes AT ruwaarddirk preferredconversationtopicswithrespecttotreatmentdecisionsamongindividualswithtype2diabetes AT brouwersmartijncgj preferredconversationtopicswithrespecttotreatmentdecisionsamongindividualswithtype2diabetes AT hiligsmannmickael preferredconversationtopicswithrespecttotreatmentdecisionsamongindividualswithtype2diabetes AT dejongjudithd preferredconversationtopicswithrespecttotreatmentdecisionsamongindividualswithtype2diabetes AT elissenariannemj preferredconversationtopicswithrespecttotreatmentdecisionsamongindividualswithtype2diabetes |